The document shows a figure of the number of drugs in development for the top 10 therapeutic areas, including drugs in various clinical trial phases and awaiting FDA approval. Cancer/blood disorders had the highest number of drugs in the pharmaceutical pipeline according to the source. The document focuses on oncology/hematology drugs.
1 of 1
Download to read offline
More Related Content
Drugs In Development 2010
1. Note: The figure shows the number of drugs in the pharmaceutical pipeline for the top 10 areas of development, including drugs in Phase I, Phase II, or Phase III, or awaiting FDA approval. Source: R&D Directions . 2010;16(6). http://www.pharmalive.com . Our focusOncology/Hematology